about
Global burden of COPD: systematic review and meta-analysisHuman exposure to volatile organic compounds: a comparison of organic vapor monitoring badge levels with blood levels.Individual and occupational characteristics associated with respiratory symptoms among Latino horse farm workersAgeing and the epidemiology of multimorbidityDefining and targeting health disparities in chronic obstructive pulmonary diseaseC-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adultsTuberculosis associates with both airflow obstruction and low lung function: BOLD resultsCOPD in never smokers: results from the population-based burden of obstructive lung disease studyChronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysisThe epidemiology of sepsis in the United States from 1979 through 2000Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population.Predictors of cotinine levels in US children: data from the Third National Health and Nutrition Examination Survey.Involuntary smoking and asthma severity in children: data from the Third National Health and Nutrition Examination Survey.Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up studyLow lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up.Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination.Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey.Active and passive smoking and blood lead levels in U.S. adults: data from the Third National Health and Nutrition Examination Survey.Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination.Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data.ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities studyOccupational exposures and COPD: an ecological analysis of international data.Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey.Recent trends in exposure to secondhand smoke in the United States populationAssociation of ambient ozone exposure with airway inflammation and allergy in adults with asthma.Wildland forest fire smoke: health effects and intervention evaluation, Hoopa, California, 1999Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.Update on the management of chronic obstructive pulmonary disease.Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes.The effect of age on the development and outcome of adult sepsis.The epidemiology of sepsis in patients with malignancy.Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.Epidemiology and costs of chronic obstructive pulmonary disease.COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries.Prevalence of airway obstruction assessed by lung function questionnaireSubjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD.Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management.Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010.
P50
Q22299203-7032E206-7E69-4965-86E9-19C5EF3CCBB6Q23911812-F94602A4-4BF1-4D94-9175-10028B785C2FQ23914656-4083D323-7F13-49B0-BFDD-42806A521B9AQ27012096-80784B0B-2C0C-4007-B206-3FDE9F25F041Q28073617-AAB3275B-41BD-4ACD-9613-52DD16E3E9EDQ28165182-E6A6C115-D985-441B-911A-FD4E25B6BCA7Q28390431-C2350DA3-617E-4190-A1C2-BE38CB127F96Q28391708-11FC9FC7-4F67-4CB0-A1A1-950AEC773291Q28658590-4FA51D48-8365-449A-B8B0-36641CE9757BQ29547760-EB21E166-1B80-4D70-8BC2-7D952427D4F9Q30370855-89E34988-B011-4F87-94F4-AB485F95A771Q30660562-77E9FCCA-B02E-46A6-88F4-15FF1DD2859EQ30712487-44BA684D-665E-42E0-820A-05E248EAB4E9Q30790513-51A73E7C-7F51-42A7-AAF9-143568A7BCCCQ30806378-8902C1E5-EAAB-4F1A-9259-B2B2BFD09D12Q30884867-C39067F4-07F5-49FC-BC3D-F2F1EDAEDB3DQ30908524-DCF4120A-2441-4D9A-9422-2BF68252C818Q30998669-98B3ED38-2BC9-4A6B-9B92-9CB2FF054D6FQ33187560-17F54385-85CC-4FED-A364-EE00D6D7DACCQ33187906-68802607-5D2D-4356-B1B2-C22BAF61B682Q33278280-4BBD9215-D8DC-44CC-B5A4-27CF77492193Q33384581-48EA9DAC-DF20-4F86-A9EE-FA03ACB917B7Q33476622-00D8E5FC-9739-4D7B-979D-AE371AC501F3Q33614167-7CB61B96-1B75-40FF-B330-5A80E523C681Q33725074-150F4CDA-CE0F-4DB3-9037-C3C33E58AE64Q33729732-F984E6E3-8514-4AC5-85E3-94657DA5D15AQ33754147-85DA8AAF-ABEF-4713-AE26-B55553DB9A4AQ33928621-1B2F6CA4-9815-4754-B9E0-BA4EAB358C4EQ34196174-02B8EBB7-BF9E-4E52-A831-87D7EAA79200Q34386883-E4757083-261F-4F9A-B862-1A04C42585AEQ34479183-6CC77607-205E-4914-8438-E7439A0F432AQ34538810-7580BCB0-2878-4DB0-AACE-4DD1887F6A33Q34557653-EE1A4AB5-6645-4FBA-B964-0CCAC137B5D0Q34563833-7A720570-C0E3-4C7F-835B-B71F33CDA432Q34637487-7988E172-7401-4758-A1F6-FB639C5FA306Q34823529-F284E3BD-0404-49EB-9EC7-A6A3A49D708CQ34887841-B4A4EC35-5645-411E-8945-E1A5BAB0983EQ35005632-4BF9A943-F788-4249-A358-D1370274108DQ35026143-A8464E24-D1C7-4B41-AB6A-FF49976A4454Q35153960-8FBBB5FA-591D-4595-A5FF-764B237BC342
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
David M. Mannino
@ast
David M. Mannino
@en
David M. Mannino
@es
David M. Mannino
@sl
type
label
David M. Mannino
@ast
David M. Mannino
@en
David M. Mannino
@es
David M. Mannino
@sl
altLabel
David Mannino
@en
prefLabel
David M. Mannino
@ast
David M. Mannino
@en
David M. Mannino
@es
David M. Mannino
@sl
P214
P227
P101
P106
P1153
7005919220
P21
P214
P227
1148793232
P31
P496
0000-0003-3646-7828
P734
P735
P7859
viaf-311808106